Pericardial effusion after definitive concurrent chemotherapy and intensity modulated radiotherapy for esophageal cancer.

ABSTRACT:

Background

The literature regarding pericardial effusion after definitive concurrent chemotherapy and intensity modulated radiotherapy (IMRT) for esophageal cancer was lacking. This study aimed to investigate the risk factors of pericardial effusion in esophageal cancer patients undergoing definitive concurrent chemotherapy and IMRT.

Methods

A total of 126 consecutive esophageal cancer patients treated with definitive concurrent chemotherapy and IMRT between 2008 and 2018 were reviewed. The pericardial effusion was determined on computed tomography scan of the chest and graded by the Common Terminology Criteria for Adverse Events, version 4.0. The cumulative incidence of pericardial effusion was estimated by the Kaplan-Meier method and compared between groups by the log-rank

SUBMITTER: Pao TH 

PROVIDER: S-EPMC7045635 | biostudies-literature | 2020 Feb

REPOSITORIES: biostudies-literature